Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Archives of Biochemistry and Biophysics
|
September 28, 2010
Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer
Hazel M Girvan, Adrian J Dunford, Rajasekhar Neeli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton
Navin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Plos One
|
November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis
Carl L Manthey, Beverley A Moore, Yanqing Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
Robin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 11, 2025
Research priorities for faecal incontinence in adults: A James Lind Alliance priority setting partnership
Alexander O'Connor, Sam Alexandra Rose, Emma V Carrington, et al.
The Journal of Biological Chemistry
|
September 27, 2008
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv
Kirsty J McLean, Paul Carroll, D Geraint Lewis, et al.
Biochemical Society Transactions
|
July 27, 2005
Biodiversity of cytochrome P450 redox systems
K J McLean, M Sabri, K R Marshall, et al.
Blood
|
November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Journal of Medicinal Chemistry
|
July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity
Cheryl A Grice, Kevin L Tays, Brad M Savall, et al.
European Journal of Cardiovascular Nursing
|
February 17, 2026
Setting research priorities for the use of digital technology in the self-management of heart health: the results of the James Lind Priority Setting Partnership
Lis Neubeck, Simon Nichols, Nicola Straiton, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Archives of Biochemistry and Biophysics
|
September 28, 2010
Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer
Hazel M Girvan, Adrian J Dunford, Rajasekhar Neeli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton
Navin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Plos One
|
November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis
Carl L Manthey, Beverley A Moore, Yanqing Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
Robin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 11, 2025
Research priorities for faecal incontinence in adults: A James Lind Alliance priority setting partnership
Alexander O'Connor, Sam Alexandra Rose, Emma V Carrington, et al.
The Journal of Biological Chemistry
|
September 27, 2008
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv
Kirsty J McLean, Paul Carroll, D Geraint Lewis, et al.
Biochemical Society Transactions
|
July 27, 2005
Biodiversity of cytochrome P450 redox systems
K J McLean, M Sabri, K R Marshall, et al.
Blood
|
November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Journal of Medicinal Chemistry
|
July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity
Cheryl A Grice, Kevin L Tays, Brad M Savall, et al.
European Journal of Cardiovascular Nursing
|
February 17, 2026
Setting research priorities for the use of digital technology in the self-management of heart health: the results of the James Lind Priority Setting Partnership
Lis Neubeck, Simon Nichols, Nicola Straiton, et al.
Page
of 7